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The transduction of sound in the auditory periphery, the cochlea, is inhibited by efferent cholinergic neurons
projecting from the brainstem and synapsing directly on mechanosensory hair cells. One fundamental question in
auditory neuroscience is what role(s) this feedback plays in our ability to hear. In the present study, we have
engineered a genetically modified mouse model in which the magnitude and duration of efferent cholinergic effects
are increased, and we assess the consequences of this manipulation on cochlear function. We generated the
Chrna9L99T line of knockin mice with a threonine for leucine change (L99T) at position 99 of the second transmembrane
domain of the a9 nicotinic cholinergic subunit, rendering a9-containing receptors that were hypersensitive to
acetylcholine and had slower desensitization kinetics. The Chrna9L99T allele produced a 3-fold prolongation of efferent
synaptic currents in vitro. In vivo, Chrna9L99T mice had baseline elevation of cochlear thresholds and efferent-
mediated inhibition of cochlear responses was dramatically enhanced and lengthened: both effects were reversed by
strychnine blockade of the a9a10 hair cell nicotinic receptor. Importantly, relative to their wild-type littermates,
Chrna9
L99T/L99T mice showed less permanent hearing loss following exposure to intense noise. Thus, a point mutation
designed to alter a9a10 receptor gating has provided an animal model in which not only is efferent inhibition more
powerful, but also one in which sound-induced hearing loss can be restrained, indicating the ability of efferent
feedback to ameliorate sound trauma.
Citation: Taranda J, Maison SF, Ballestero JA, Katz E, Savino J, et al. (2009) A point mutation in the hair cell nicotinic cholinergic receptor prolongs cochlear inhibition and
enhances noise protection. PLoS Biol 7(1): e1000018. doi:10.1371/journal.pbio.1000018
Introduction
In bringing information about the world to an individual,
sensory systems perform a series of common functions. Each
system responds with some speciﬁcity to a stimulus, and each
one employs some specialized receptor cells at the periphery
to translate speciﬁc stimuli into electrical signals that all
neurons can use. That initial electrical event begins the
process by which the central nervous system constructs an
orderly representation of, for example, sounds, odors, tastes,
and objects. Thus, basic sound detection begins when sound
waves strike the eardrum, which transmits that physical
stimulus to the organ of Corti within the cochlea, the sensory
epithelium of the mammalian inner ear. Here, the primary
receptor cells known as inner hair cells (IHCs) transform the
information into electrical signals that are sent to the central
nervous system by the auditory nerve [1]. However, unlike
vision, touch, and the chemical senses, sound processing is
modulated by efferent signals that travel in reverse, from the
brain back to the inner ear [2]. One fundamental question in
auditory neuroscience is what role(s) this feedback plays in
our ability to hear.
The medial olivocochlear (MOC) efferents (Figure 1A)
originate in the medial portion of the superior olivary
complex and project to outer hair cells (OHCs; Figure 1B) of
the organ of Corti, where large synaptic contacts are formed
[2]. In contrast to IHCs, OHCs act as biological motors to
amplify the sound-evoked motions of the organ of Corti
through a type of somatic electromotility generated by a
specialized membrane protein known as prestin. Activation
of the MOC pathway, either by sound or by shock trains
delivered to the bundle at the ﬂoor of the IVth ventricle
(Figure 1A), reduces cochlear sensitivity through the action of
the neurotransmitter acetylcholine (ACh) on nicotinic re-
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PLoS BIOLOGYceptors (nAChRs) at the base of OHCs (Figure 1C) [3].
Although signiﬁcant progress has been made in deﬁning the
cellular mechanisms of hair cell inhibition [3], the functional
role(s) of this sound-evoked feedback system, including
control of the dynamic range of hearing [2], improvement
of signal detection in background noise [4–6], mediating
selective attention [7,8], and protection from acoustic injury
[9], remain controversial.
In addition to their signiﬁcance in auditory processing,
efferent cholinergic synapses provide a unique opportunity
to assess the function of neuronal nAChRs. In contrast to
nAChR-expressing cells in the central nervous system [10],
hair cells are compact and isopotential, and receive no other
synaptic inputs. Moreover, compared to most other neuronal
nAChRs, whose subunit composition remains challenging to
elucidate [11], the oligomeric structure of the hair cell nAChR
has been deﬁned: a9a n da10 subunits arrange into a
pentameric assembly with a likely (a9)2(a10)3 stoichiometry
[12–15]. Current data support the notion that activation of
the a9a10 nAChR leads to an increase in intracellular Ca
2þ
and the subsequent opening of small conductance Ca
2þ-
activated K
þ SK2 channels, thus leading to hyperpolarization
of hair cells [3,16,17], (Figure 1C).
In the present study, we have generated a genetically
modiﬁed mouse model in which the magnitude and duration
of the MOC efferent effect is increased, and assessed the
consequences of this manipulation on auditory thresholds
and susceptibility to noise-induced hearing loss. We have
substituted a threonine for a leucine at position 99 (L99T)o f
the second transmembrane domain of the a9 subunit and
examined the neurotransmitter responses, synaptic efﬁ-
ciency, and cochlear function of Chrna9
wt/wt, Chrna9
wt/L99T,
and Chrna9
L99T/L99T mice. We show that the L99T mutation
produced an increase in sensitivity to ACh, and decreased
rates of ACh-induced desensitization. More signiﬁcantly,
synaptic currents were dramatically prolonged in the OHCs
of Chnra9
L99T/L99T mice. Consistent with these effects,
Chnra9
L99T/L99T mice had elevated acoustic thresholds, and
shock-evoked MOC activation produced both enhanced and
prolonged cochlear suppression. This enhanced efferent
inhibitory drive attenuated sound-induced, permanent
acoustic injury. Our results establish efferent feedback
inhibition’s function in preventing acoustic trauma, and
provide preliminary characterization of a mouse model to
explore additional physiological functions of MOC innerva-
tion. In addition, it motivates further exploration of the
efferent synapse as a model system to study fast neuro-
transmission mediated by a neuronal nAChR.
Results
The targeting construct and generation of Chrna9L99T
mutant mice are described in the Materials and Methods
section and Figure 2. Both Chrna9
wt/L99T and Chrna9
L99T/L99T
mutant mice were viable through adulthood, fertile, showed
the expected gender and Mendelian genotype ratios, and
exhibited no overt behavioral phenotype. Gross morphology
of the cochlear duct was normal as seen in light microscopic
evaluation of plastic sections of osmium-stained cochleae
Figure 1. Schematics Showing the Central Origin (A) and Peripheral Projections (B) of the MOC Fibers and the Cholinergic Synapse onto OHCs in the
Mature Organ of Corti (C)
MOC efferent neurons are located in the superior olivary complex of the brainstem and project to the cochlea, where they make direct synaptic contacts
at the base of the OHCs. At this synapse, ACh is released. It binds to a9a10 receptors present at the OHCs, leading to Ca
2þ influx and the subsequent
activation of Ca
2þ-dependent SK2 K
þ channels and hair cell hyperpolarization. The black arrow in (A) indicates the place of electrical stimulation to
activate the MOC fibers. The white arrow in (B) indicates the afferent fibers that bring the information from the IHCs to the central nervous system, and
the red arrow indicates the MOC fibers. For approximately 10 d after birth (before the onset of hearing), cholinergic efferents temporarily synapse
directly with IHCs (not shown in the figure) and provide a useful experimental target for the study of altered a9a10 receptors.
doi:10.1371/journal.pbio.1000018.g001
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Author Summary
Nicotinic cholinergic receptors are essential to higher order brain
function. Structurally, these operate through a myriad of ligand-
gated pentameric arrangements of different homologous subunits.
Here, we report progress in understanding the structural properties
of a neuronal nicotinic receptor at the synapse. Receptors
assembled from two nicotinic cholinergic subunits (a9 and a10)
serve exclusively at the synapse between central nervous system
descending fibers and cochlear hair cells. This enabled us to show
direct causality between a point mutation of the a9 subunit, and
predicted alterations in the synaptic strength in sensory hair cells of
the cochlea of a9 point mutant mice. Furthermore, this single
mutation results in profound enhancement of central nervous
system feedback to the cochlea. And finally, as a consequence,
mutant mice possessing this altered receptor have substantially
improved resistance to traumatic sound. Thus, central neuronal
feedback on cochlear hair cells provides an opportunity to define
one specific role that nicotinic receptors can play in the nervous
system, enabling study from biophysical to behavioral levels and
promoting a target for the prevention of noise-induced hearing loss.(Figure S1). As assessed by quantitative real-time PCR (RT-
PCR), the expression level of cochlear nAChR a9 subunit
mRNA was similar in Chrna9
wt/wt and Chrna9
L99T/L99T mice
(Table S1). In addition, the expression levels of genes
encoding proteins known to localize to the olivocochlear
(OC) synaptic complex (for example, the nAChR a10 subunit
and SK2 channel) were not changed in mutant mice (Table
S1). Lastly, the electrophysiology of IHCs and OHCs was
normal, as indicated by similar voltage-dependent K
þ
currents (Figure S2). Hair cell membrane area measured by
capacitance was identical across phenotypes (Chrna9
wt/wt: 8.3
6 0.2 pF, n¼19 animals, 41 IHCs; Chrna9
wt/L99T: 8.4 6 0.1 pF; n
¼ 14 animals, 41 IHCs; Chrna9
L99T/ L 9 9T: 8.6 6 0.1 pF, n ¼ 26
animals, 79 IHCs, measured at P9–P11; Chrna9
wt/wt: 8.0 6 0.4
pF, n¼5 animals, 13 OHCs; and Chrna9
L99T/ L 9 9T: 8.1 6 0.2 pF,
n ¼ 8 animals, 19 OHCs, measured at P10–P11).
Hypersensitive and Slowly Desensitizing nAChRs in
Mutant Mice
In Xenopus oocytes, a9a10 nAChRs assembled from mutant
a9L99T subunits exhibit an increased sensitivity to ACh, a
reduced desensitization rate, and an increased channel mean
open time [18]. To determine whether similar changes
occurred in hair cells of L99T mutant mice, we examined
the response of neonatal IHCs to exogenous ACh. IHC
nAChRs, which are expressed transiently before the onset of
hearing, are of the a9a10 subtype and are functionally
indistinguishable from those that arise later in OHCs [19,20].
Figure 2. Genetic Engineering and Genotyping of Chrna9L9’T Mutant Mice
(A) Gene structures and restriction maps for the targeting construct, wild-type, and recombinant alleles (before and after removal of the neomycin
resistance cassette) are shown. Black boxes represent the exons of the Chrna9 gene. The introduction of the mutation is shown by an asterisk (*).
(B) An autoradiograph of a genomic Southern blot using DNA prepared from wild-type (left lane) and successfully targeted ES cells (right lane) and
hybridized to a 32P-labled DNA probe prepared from the 962-bp SacII-KpnI fragment shown. Wild-type (WT) ES cell DNA yield a fragment of 13,800 bp,
whereas ES cells that have undergone homologous recombination yield a 7,300-bp fragment.
(C) Routine genotyping of neo-deleted Chrna9L99T mutant mice performed by PCR from isolated tail biopsy tissue genomic DNA samples and
amplimers flanking the lox P footprint (white box). A representative gel indicating the results for wild-type, heterozygous, and homozygous knockin
mice is shown. The PCR fragment length for the wild-type Chrna9 allele is 203 bp, and 269 bp for the mutant allele. MW, molecular weight.
(D) A PCR fragment using amplimers flanking the L99T mutation (Figure 1A) was obtained from genomic DNA isolated from tail biopsies and sequenced
to check the integrity of the mutation in each breeding pair. A representative electropherogram indicating the results for wild-type and homozygous
knockin mice is shown. The wild-type sequence at nucleotide position 210, corresponding to the codon at position 99 in the second transmembrane
domain, is TTG, encoding leucine; the mutant sequence is ACG, encoding threonine.
doi:10.1371/journal.pbio.1000018.g002
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from neonatal IHCs than OHCs, the former provided the
bulk of the data presented. As shown below, a subset of our
ﬁndings has been repeated in OHCs of Chrna9L99T mutant
mice.
As observed in Figure 3A, IHCs of Chrna9
wt/L99T and
Chrna9
L99T/L99T mice responded to ACh at P6–P10. In each
case, ACh dose-response curves of IHCs were left-shifted
when compared to wild type, with a concomitant decrease in
the half maximal effective concentration (EC50). The EC50 was
signiﬁcantly different (p , 0.01) between homozygous mutant
and wild-type IHCs (Chrna9
wt/wt:E C 50, 90.8 6 18.2 lM, Hill
coefﬁcient 1.6 6 0.1, n¼4 animals, 7 cells; Chrna9
wt/L99T:E C 50,
57.2 6 6.5 lM, Hill coefﬁcient 2.2 6 0.1, n¼4 animals, 9 cells;
and Chrna9
L99T/ L 9 9T:E C 50, 41.7 6 5.7 lM, Hill coefﬁcient 2.1
6 0.2, n ¼ 4 animals, 7 cells). During prolonged (.60 s)
application of 1 mM ACh at  90 mV (Figure 3B), the current
was entirely inward since the ACh response was recorded in
isolation from the SK2 component (see below). The evoked
membrane current in wild-type IHCs decayed with a complex
time course. In IHCs of both Chrna9
wt/L99T and Chrna9
L99T/L99T
mice, ACh-evoked membrane current was more sustained
than that seen in wild-type mice (i.e., showed reduced
desensitization, as previously shown with recombinant
a9a10 nAChRs expressed in oocytes [18]). The fraction of
current remaining after a 30-s ACh application was 0.29 6
0.04 in Chrna9
wt/wt (n ¼ 10 animals, 15 cells), 0.45 6 0.05 in
Chrna9
wt/L99T (n¼9 animals, 12 cells, p , 0.05), and 0.48 6 0.06
in Chrna9
L99T/L99T (n ¼ 6 animals, 10 cells, p , 0.05).
Prolonged Synaptic Currents in Mutant IHCs
Following efferent transmitter release in vitro, spontane-
ous inhibitory postsynaptic currents (sIPSCs) can be meas-
ured in neonatal IHCs. As determined for MOC synapses
located on OHCs, the IHC inhibitory postsynaptic currents
(IPSCs) result from ion ﬂux through a9a10 nAChRs and
calcium-activated SK2 channels [19,20], (Figure 1C). To only
measure currents through a9a10 nAChRs, responses were
recorded using pipettes ﬁlled with KCl-BAPTA (thereby
preventing calcium from activating SK2 channels) and 5 nM
apamin (an SK channel blocker) in the extracellular solution.
As shown in Figure 4A and detailed in Table 1, these
‘‘nAChR-only’’ sIPSCs of mutant mice were dramatically
prolonged compared to wild type. There was a 6-fold increase
in the sdecay, no difference in srise, and a 3-fold increase in the
duration at half amplitude (halfwidth). In addition, the sIPSCs
in Chrna9
L99T/L99T IHCs had signiﬁcantly smaller amplitudes
than those of wild-type IHCs. Despite the amplitude
reduction, overall charge transfer (as indicated by the area
value) of the ‘‘nAChR-only’’ synaptic current was more than
doubled in Chrna9
L99T/L99T when compared to Chrna9
wt/wt
IHCs.
When sIPSCs were recorded with KCl-EGTA in the pipette,
currents were inward at  90 mV and outward at  40 mV
(Figure 4B). As noted for wild-type IHCs ([19,20] and present
results), the polarity shift of the sIPSC indicates that SK2
channel gating occurs in the Chrna9L99T mutant mice. At 90
mV, sIPSCs of Chrna9
L99T/L99T mice were dramatically pro-
longed compared to Chrna9
wt/wt, with a 4- and 3-fold increase
in the sdecay and halfwidth, respectively. At 40 mV, sdecay and
halfwidth were 3-fold greater than in wild type, and a slight
increase in srise also was observed. The peak current at  40
mV, carried by SK2 channels, was equivalent in Chrna9
wt/wt
and Chrna9
L99T/L99T IHCs. Nonetheless, the smaller amplitude
nAChR-only current observed in IHCs of mutant mice
activates SK2 channels as effectively as in wild-type IHCs.
Indeed, the area under the Chrna9
L99T/L99T SK2 current was
nearly three times greater than that of the Chrna9
wt/wt SK2
current. Presumably, this enhancement results from the
increased total calcium ion ﬂux during the prolonged activity
of the nAChRs in mutant mice.
As shown in Figure 4C, synaptic activity evoked by 40 mM
K
þ in IHCs was reversibly blocked by the a9a10 blocker
strychnine (300 nM) [13], indicating that the synaptic activity
observed in Chrna9
L99T/L99T was in fact mediated through
mutant a9a10 nAChRs.
Prolonged Synaptic Currents and Coupling to SK2
Channels in Mutant OHCs
Since hair cell sIPSCs were infrequently observed, synaptic
currents and the effects of exogenous ACh were measured in
P10–P11 OHCs using high-potassium buffer (40 mM K
þ plus
Figure 3. Hypersensitive and Slowly Desensitizing ACh Responses
(A) Concentration-response curves to ACh performed in P9–P10 IHCs. Peak current values were normalized and referred to the maximal peak response
to ACh in each case. The mean and S.E.M. of experiments performed in n¼7 cells (4 animals) for Chrna9
wt/wt, 9 cells (4 animals) for Chrna9
wt/L99T, and 7
cells (4 animals) for Chrna9
L99T/L99T are shown; (B) Wave-form of responses to ACh in P6–P10 IHCs voltage-clamped at 90 mV. Representative responses
to the application of 1 mM ACh during 1 min are shown. WT, wild type.
doi:10.1371/journal.pbio.1000018.g003
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(Figure 5A and 5B). Under these recording conditions, the
synaptic waveform includes current through both the nAChR
and associated SK2 channels (entirely inward at 90 mV since
40 mM K
þ shifts the equilibrium potential of this cation to
 33 mV). Analysis of waveforms revealed a 4- and 3.5-fold
increase in sdecay and halfwidth, respectively, and a 0.6-fold
reductioninamplitude(Figure5CandTable2)inChrna9
L99T/L99T
IPSCs compared to Chrna9
wt/wt, much as was observed in IHCs.
Despite a drop in amplitude, the overall charge transfer (as
indicated by the area value) was 2-fold larger in Chrna9
L99T/L99T
compared to Chrna9
wt/wt OHCs.
Under these recording conditions, synaptic currents reﬂect
ion ﬂux through both nAChRs and associated SK2 channels.
Figure 4. Prolonged Synaptic Currents in IHCs Are Blocked by Strychnine
(A) Superimposed representative traces from individual cells of nAChR-only sIPSCs in IHCs from a Chrna9
wt/wt; (27 events) and a Chrna9
L99T/L99T (27
events) mice at a Vhold (Vh) of  82 mV.
(B) Superimposed representative traces from individual cells of nAChRþSK synaptic currents in IHCs at a Vhold of 90 mV from a Chrna9
wt/wt (84 events)
and a Chrna9
L99T/L99 (16 events), and of 40 mV from a Chrna9
wt/wt (54 events) and a Chrna9
L99T/L99 (14 events). The representative traces shown are the
average of the different events in one cell (number of cells per experiment indicated in Table1). WT, wild type.
(C) Representative traces (n ¼ 4 IHCs, 2 animals) of synaptic currents evoked by 40 mM external K
þ at Vhold of  90 mV in Chrna9
L99T/L99. The blow-ups
show IPSCs, which disappear in the presence of 300 nM strychnine.
doi:10.1371/journal.pbio.1000018.g004
Table 1. Synaptic Currents in IHCs from Chrna9
wt/wt and Chrna9
L99T/L99T Mice
Currents nAChR nAChR þ SK2
Vhold  82 mV  40 mV  90 mV
Genotype wt/wt L99T/L99T wt/wt L99T/L99T wt/wt L99T/L99T
Amplitude (pA) 18.4 6 2.1 11.1 6 1.01
a 28.2 6 1.1 30.2 6 3.3 20.9 6 1.9 16.7 6 0.9
srise (ms) 0.8 6 0.1 0.8 6 0.2 8.6 6 1.2 18.6 6 1.3
a 5.4 6 1.0 9.3 6 1.9
sdecay (ms) 27.9 6 1.0 186 6 26
c 52.9 6 10.1 170 6 37
a 53.7 6 5.4 222 6 47
b
Halfwidth (ms) 25.0 6 1.2 79.2 6 10.3
b 66.5 6 2.8 194 6 23
b 70.3 6 6.0 235 6 51.1
b
Area (pC) 0.55 6 0.09 1.1 6 0.1
a 2.0 6 0.1 5.7 6 1.4
a 1.4 6 0.1 3.9 6 1.0
a
Number of animals 2 3 3 2 4 3
Number of cells 4 4 3 2 6 5
Number of events 1125 141 83 55 277 141
ap , 0.05.
bp , 0.01.
cp , 0.001.
wt, wild type.
doi:10.1371/journal.pbio.1000018.t001
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strated directly by application of ACh to Chrna9
L99T/L99T
OHCs held at different membrane potentials. As shown in
Figure 5D, ACh responses were outward at  40 mV,
conﬁrming the activation of potassium currents in mutant
OHCs.
Increased Cochlear Thresholds in Mutants Can Be
Reversed with Strychnine
We examined cochlear responses in Chrna9L99T mutant
mice via auditory brainstem responses (ABRs) and distortion
product otoacoustic emissions (DPOAEs). Wave 1 of the ABR,
which is recorded from scalp electrodes in response to short
tone pips, represents the summed activity of cochlear nerve
ﬁbers projecting from IHCs (Figure 1B) to the cochlear
nucleus, the ﬁrst central nucleus in the ascending auditory
pathway [21]. The DPOAEs are sounds created within the
cochlea, ampliﬁed by the action of OHCs and propagated
through the middle ear back to the ear canal, where they can
be measured with a microphone [22]. Given that the
generation of DPOAEs requires neither IHCs nor cochlear
nerve ﬁbers [23], a comparison of ABRs and DPOAEs can
provide insight into the locus of any dysfunction.
As shown in Figure 6A, mean ABR thresholds were elevated
by 5–15 dB in both Chrna9
wt/L99T (F(1,55) ¼ 4.30, p ¼ 0.043) and
Chrna9
L99T/L99T (F(1,79) ¼ 7.87, p ¼ 0.06) when compared to
Chrna9
wt/wt mice. DPOAE thresholds (Figure 6B) were also
elevated by 5–15 dB in both Chrna9
wt/L99T (F(1,53) ¼ 14.82, p ,
0.001) and Chrna9
L99T/L99T (F(1,77) ¼ 9.20, p ¼ 0.003). Threshold
shifts were larger at frequencies above 16 kHz and were
similar in magnitude whether measured by ABRs or DPOAEs,
suggesting that all dysfunction can be explained by changes in
OHC contributions to cochlear ampliﬁcation.
Since MOC activity in vivo decreases OHC-based ampliﬁ-
cation of cochlear responses [2], we asked whether the
increased cochlear thresholds might arise from enhanced
synaptic currents through mutant a9-containing channels in
response to the normal low level of spontaneous MOC
activity [24]. To test this hypothesis, we injected mice with
strychnine (30 mg/kg, intraperitoneally [i.p.]), a potent
blocker of a9a10 channels [13,25]. Indeed, as shown in Figure
7, strychnine improved acoustic thresholds in Chrna9
L99T/L99T
Figure 5. Prolonged Synaptic Currents in OHCs
(A) Representative traces of IPSCs evoked by 40 mM K
þin OHCs of P10–P11 Chrna9
wt/wt mice at a Vhold of 90 mV. The insets show synaptic currents on
an expanded time scale.
(B) Same as in (A) but for Chrna9
L99T/L99T mice.
(C) Superimposed representative traces of nAChRþSK2 synaptic currents from a Chrna9
wt/wt; (39 events) and a Chrna9
L99T/L99T (77 events) mice. The
representative traces shown are the average of the different events in one cell (number of cells per experiment indicated in Table 2). Vh, Vhold; WT, wild
type.
(D) Representative responses of OHCs to 1 mM ACh at a Vhold of  90 mV and  40 mV.
doi:10.1371/journal.pbio.1000018.g005
Table 2. Synaptic Currents in OHCs from Chrna9
wt/wt and
Chrna9
L99T/L99T Mice
Currents nAChR þ SK2
Vhold  90 mV
Genotype wt/wt L99T/L99T
Amplitude (pA) 207 6 25 129 6 11
a
srise (ms) 4.7 6 0.2 10.2 6 0.4
c
sdecay (ms) 32.6 6 1.7 123.668
c
Halfwidth (ms) 47.2 6 1.7 161.4 6 13.0
c
Area (pC) 11.1 6 1.6 20.663.2
b
Number of animals 2 3
Number of cells 6 3
Number of events 780 208
ap , 0.05.
bp , 0.01.
cp , 0.001.
wt, wild type.
doi:10.1371/journal.pbio.1000018.t002
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a9 nAChR Point Mutant & Noise Protectionmice by almost 9 dB, thus restoring the baseline thresholds to
that seen in the wild type.
Shock-Evoked OC Suppression Is Slowed, Enhanced, and
Prolonged in Mutants
Activation of MOC efferents normally decreases the OHC
contribution to cochlear ampliﬁcation. Thus, the electrical
stimulation of the MOC ﬁbers at the ﬂoor of the IVth
ventricle (Figure 1A, black arrow) results in a decrease in the
amplitude of the DPOAEs [25]. To assess MOC function in
vivo, DPOAEs were measured before, during, and after a 70-s
train of shocks to the olivocochlear bundle. In wild-type mice,
DPOAE suppression is seen immediately after shock-train
onset (Figure 8A, black arrowhead) and then adapts to a
steady state, which is maintained throughout the shock epoch
(Figure 8A and 8B). In Chrna9L99T mutant mice, suppression
had a much slower onset (Figure 8A, white arrowhead), but
continued to grow during the shock train (Figure 8A and 8B)
until responses disappeared into the noise ﬂoor. To deter-
mine the full suppression magnitude, we raised the level of
the acoustic stimulus (Figure 8C): peak suppression in
Chrna9
L99T/L99T reached approximately 17 dB, whereas for
Chrna9
wt/wt, the maximum suppression was less than approx-
imately 5 dB. In homozygous mutants, suppression persisted
for almost 10 min after the end of the shock train, with a slow
recovery to baseline (Figure 8B). Moreover, there is a
prominent ‘‘overshoot,’’ which, except for a slower time
course, is reminiscent of the post-shocks enhancement seen
in wild-type mice [25]. As shown in Figure 8A and 8B,
responses in Chrna9
wt/L99T were intermediate between those of
homozygous mutant and wild-type mice.
As with wild-type mice [25], suppression could be blocked
by strychnine (10 mg/kg), leaving only the postshock enhance-
ment (Figure 9A, grey arrowhead), suggesting that the
increased suppression in Chrna9L99T mutants was due to
the enhanced activity of a9a10 receptors. With a lower dose
of strychnine (3 mg/kg), suppression in Chrna9
L99T/L99T
resembled the normal Chrna9
wt/wt response (i.e., reduced
suppression magnitude but with rapid onset and decay;
Figure 9B, grey arrowhead).
Chrna9L99T Mutant Mice Are More Resistant to Permanent
Acoustic Injury
Given that MOC activation most likely results in a decrease
in acoustic injury [26–28], we investigated the susceptibility of
Chrna9L99T mutant mice to intense noise. Since the mecha-
nisms underlying reversible and irreversible noise-induced
threshold shifts are different [29,30], we used two different
noise exposures to induce either a temporary (TTS) or
permanent (PTS) threshold shift. Homozygous mutant mice
showed increased resistance to permanent acoustic injury
when compared to wild type (Figure 10A, 5.0–45.2 kHz,
Chrna9
L99T/L99T: F(1,8) ¼ 8.894, p ¼ 0.018; Chrna9
wt/L99T: F(1,7) ¼
6.263, p¼0.041). With a lower intensity exposure designed to
produce a TTS, there was no signiﬁcant difference in
vulnerability between wild-type and mutant mice, when
examined 12 h after exposure (Figure 10B).
Discussion
The present study demonstrates that substitution of a
single amino acid in transmembrane region 2 of the a9
subunit (L99T) enhances nAChR function in cochlear hair
cells (i.e., decreased ACh EC50 and slowed receptor desensi-
tization rate), increases synaptic efﬁcacy, and dramatically
strengthens cochlear suppression in vivo. More importantly,
it shows that the MOC efferent system inhibits cochlear
Figure 6. Baseline Cochlear Thresholds Are Elevated in Mutant Ears, as
Measured by either ABRs (A) or DPOAEs (B)
Mean group values 6 S.E.M. are shown and numbers of ears measured in
each group are indicated in the key in (A). ABR thresholds were identified
by visual inspection of the stacked level-series waveforms. DPOAE
threshold was defined by interpolation as the sound pressure of the f2
primary required to evoke a DPOAE of 0 dB SPL. WT, wild type.
doi:10.1371/journal.pbio.1000018.g006 Figure 7. Strychnine Improves Cochlear Thresholds in Mutant Mice
By 1 h postinjection, thresholds in mutant mice recovered to the mean
value from wild types (23 dB SPL at 22.6 kHz: Figure 5B). Strychnine
produced no systematic effects on wild-type (WT) thresholds. Here,
DPOAE thresholds for f2 ¼ 22.6 kHz were repeatedly measured before
and after a 30-mg/kg i.p. strychnine injection in a Chrna9
wt/wt and a
Chrna9
L99T/L99T. The effect of strychnine was concentration-dependent as
shown in Figure S3.
doi:10.1371/journal.pbio.1000018.g007
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Thus, the efferent pathway provides a promising target for
pharmacological prevention of inner ear pathologies derived
from acoustic injury, such as hearing loss and tinnitus.
The Hair Cell as a Model System to Study the Nicotinic
Synapse
Understanding neurotransmission mediated by neuronal
nicotinic receptors is a fundamental challenge in neuro-
science, since decline, disruption, or alteration of nicotinic
cholinergic mechanisms in the central nervous system
contributes to dysfunctions such as epilepsy, schizophrenia,
Parkinson’s disease, autism, dementia with Lewy bodies,
Alzheimer’s disease, and addiction [10]. Although fast, direct
nicotinic synaptic activity drives neurotransmission in auto-
nomic ganglia, only rare cases of fast nicotinic transmission
mediated by neuronal nAChRs have been reported in the
mammalian brain. Because cholinergic neurons in the brain
are usually loosely distributed and often sparsely innervate
broad areas, it is experimentally difﬁcult to stimulate a large
number of those neurons and to record selectively from their
postsynaptic targets. Indeed, it is likely that authentic fast
nicotinic transmission is present at low densities in more
neuronal areas than the few that have been reported [10].
Furthermore, the variable transcription of genes coding for
nAChR subunits and the possible combinatorial assembly of
these subunits produces a wide structural diversity of
receptor types. This imposes additional challenges for study-
ing native synaptic neuronal nAChRs [31].
Thus, the cholinergic synapse between MOC terminals and
cochlear hair cells provides a valuable model for the study of
fast neurotransmission mediated by nAChRs of known
composition [12,13]. Targeted mutations can be introduced
and the phenotypic consequences can be analyzed at the
synaptic, whole-organ, and systems level. When analyzed at the
level of nAChR function, the a9 L99T mutant mice reproduce
what has been previously described for the recombinant
receptor expressed in oocytes, i.e., a decrease in EC50 for ACh
and a reduced desensitization kinetics [18]. Both these effects
probably derive from the fact that the L99 position of nAChRs
is critical for channel gating [32] and that hydrophilic
substitutions at this position lead to increased mean open
times [18,33]. Moreover, these changes in channel gating
properties translate into increased synaptic efﬁcacy, as seen
from the prolonged synaptic currents observed in IHCs and
OHCs of mutant mice. In addition, the inhibitory signature of
the efferent synapse is conserved, since the nAChR currents
remain coupled to the associated SK2 currents, which were
also substantially prolonged. In fact, the increase in overall
charge transfer during sIPSCs between wild-type and knockin
mice was more pronounced when the secondary SK2 currents
were measured, than for the nAChR-only currents (Table 1),
pointing to an additional ampliﬁed step, possibly calcium-
induced calcium release from the nearby synaptic cistern [34].
Finally, the ﬁnding that the L99T mutation does not lead to
hair cell death, is distinct from effects of similar mutations in
a4 and a7 nAChR subunits, which lead to death of substantia
nigra dopaminergic neurons [35] and apoptotic cell death
throughout the somatosensory cortex [36], respectively, most
likely due to Ca
2þ excitotoxicity. The observation that a9a10
receptors are indeed highly permeable to Ca
2þ [37,38] points
toward an efﬁcient Ca
2þbuffering system in hair cells. In fact,
proteinaceous calcium buffers (e.g., parvalbumin-b) are ex-
pressed in OHCs at high levels, similar to those found in
skeletal muscle [39].
Functional Consequences of Enhanced nAChR Gating
The main peripheral effect of the MOC activity is to inhibit
cochlear responses by decreasing the gain of the cochlear
ampliﬁer [2]. MOC neurons comprise the effector arm of a
sound-evoked negative feedback system that, in a quiet
environment, normally has little effect on cochlear sensitivity,
Figure 8. OC-Mediated Suppression of Cochlear DPOAEs Is Slowed, Enhanced and Prolonged in Mutant Mice
(A) and (B): DPOAE amplitudes measured before, during, and after a 70-s shock train to the OC bundle (grey boxes) are shown on two different time
scales to emphasize the onset effects (A) and the offset effects (B) of OC activation. DPOAE amplitudes from each experiment are normalized to the
average preshock value and then averaged across ears within a genotype (group sizes are shown in the key in (A). Arrowheads in (A) indicate the first
point after shock-train onset for each genotype: data acquisition times are approximately 1s/point. For (A) and (B), the f2 primary was at 22.6 kHz, and
primary levels were adjusted to produce a DPOAE approximately 15 dB above the noise floor: suppression is so strong in mutant ears that the DPOAEs
are driven into the noise. WT, wild type.
(C) To reveal full suppression magnitude, we raised primary levels until preshock DPOAEs were 25 dB above the noise floor: peak suppression in
Chrna9
L99T/L99T reached approximately 17 dB, whereas for Chrna9
wt/wt, effects were less than approximately 5 dB at these higher stimulus levels.
doi:10.1371/journal.pbio.1000018.g008
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and do not respond to sound until levels exceed threshold by
15–20 dB [24]. The fact that the baseline threshold elevation
in L99T mutants can be ‘‘rescued’’ via strychnine, the potent
a9a1 0n A C h Rb l o c k e r ,s u g g e s t st h a ti ta r i s e sf r o ma n
enhancement of cholinergic effects on OHCs. Therefore,
compared to Chrna9 and Chrna10 knockouts, in which
baseline cochlear thresholds were normal [40,41], the present
knockin strategy reveals cholinergic MOC effects under
resting conditions. This baseline inhibition could arise from
an increased sensitivity of mutant receptors to normal low
levels of spontaneous ACh release from MOC terminals or to
the increased probability of spontaneous channel openings of
L99T mutant receptors in the absence of ACh [18]. The
appearance of spontaneous channel openings, as described
for the mutant receptors [18], may also explain how low-dose
strychnine can speed the onset kinetics of the in vivo
response in mutant mice (Figure 9B), i.e., by restoring mutant
channels to the closed state, from which rapid ACh-mediated
channel openings can occur.
Hair cell recordings from the L99T mutant mice in the
present study show (1) ACh-evoked currents with a greatly
reduced desensitization rate, and (2) spontaneous miniature
synaptic currents with slower activation and decay kinetics.
These changes in ACh response kinetics provide likely
explanations for some aspects of the electrically evoked
suppression of DPOAEs. The doubling of onset time for the
ACh-evoked SK2 current in mutant hair cells (Table 1) must
contribute to the slowed onset of MOC-mediated suppression
in vivo, by reducing linear summation of postsynaptic effects.
However, the slowing of suppression onset is so dramatic
(,1 s in wild type vs. .20 s in mutant mice) that other
possible factors, e.g., alterations of release probability or
slowed facilitation in the efferent terminals [42], might also
contribute to this delayed time course.
In addition to rising more slowly, MOC-mediated cochlear
suppression was also larger and longer lasting in L99T mutant
mice. The normal adaptation of suppression during contin-
uous MOC activation was absent in the presence of slowly
desensitizing a9L99T mutant receptors, consistent with the
idea that receptor desensitization is a key factor in the decay
of the wild-type response after shock-train onset. However,
the dramatic prolongation of cochlear suppression after
shock-train offset (500 s in mutants vs. ,5 s in wild types) is
too large to be explained only by the 2- to 3-fold
prolongation of synaptic currents observed in the mutant
hair cells. Another contributing factor may be the observa-
tion that choline, the metabolite produced when acetylcho-
linesterase degrades ACh released at the synapse, is a full
agonist of the mutant a9a10 receptor, and only a weak partial
agonist of the wild-type receptor [18]. Thus, in vivo, the
suppression can only decay after choline is taken up by the
synaptic terminal or otherwise diffuses away. Treatment with
a low dose of the a9a10 antagonist strychnine (3 mg/kg)
supports this interpretation. This treatment completely
abolished the prolonged postshock suppression in mutant
mice (and unmasked a fast onset). Since choline has 4-fold
lower afﬁnity for a9L99T mutant receptors than ACh [18], a
low concentration of strychnine may be differentiating the
effects of the two agonists (i.e., blocking the effects of the
agonist with a lower potency, choline, but leaving unchanged
the effects of the high-afﬁnity agonist, ACh), as well as
modulating the resting level of desensitization. Beyond the
possibility of metabolite activation, extended inhibitory
effects could involve more than changes in membrane
conductance. For example, it has been shown that exposure
to ACh alters the stiffness and motility of OHCs isolated from
the gerbil cochlea over tens of minutes [43]. Stiffness and
motility of OHCs depends, at least in part, on the motor
protein prestin, a molecule that has selectively evolved in
mammals to subserve somatic electromotility and ampliﬁca-
tion [44,45]. Thus, it remains to be determined whether
prolonged Ca
2þ inﬂux through mutated a9a10 receptors
leads to changes in prestin structure or function resulting in
prolonged MOC efferent effects.
The presence of mutant a9L99T receptors, designed to
increase the magnitude of MOC effects on OHCs, also
increased the protective action of the MOC system in vivo.
Figure 9. Strychnine Blocks OC Suppression in Mutant Ears
(A) At 10 mg/kg, strychnine injection blocked OC-mediated DPOAE suppression in mutant mice, leaving only the slow OC-mediated enhancement seen
in Chrna9 null mice [25].
(B) At a lower strychnine dose (3 mg/kg), the onset of suppression in the mutant mice becomes more rapid, closely resembling the wild-type response
without strychnine (Figure 7). Arrowheads in (A) and (B) indicate the first point after shock-train onset for each genotype: data acquisition times are
approximately 1/point.
doi:10.1371/journal.pbio.1000018.g009
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expression of wild-type a9 channels, which more modestly
increased the magnitude of MOC-mediated DPOAE suppres-
sion, also increased the resistance of the ear to acoustic injury
[26]. Prior in vivo studies of electrically evoked MOC activity
have described both fast and slow effects of ACh on cochlear
neural responses [46,47] and cochlear mechanical vibrations
[48]. The fast suppression, with an onset time course of
approximately 100 ms, arises from the increased K
þ con-
ductance in neighboring SK2 channels and the effects of the
resultant OHC hyperpolarization on the magnitude of
electromotility and thus on cochlear vibration amplitude.
The slow suppression, with an onset time course of
approximately 10 s, may require a wave of calcium-induced
calcium release along the OHC membrane and appears to
reﬂect a change in OHC stiffness [48] that also reduces
cochlear vibrations. The observation that overexpression of
SK2 channels does not increase resistance to acoustic injury
[49], although as with a9 overexpression, it also increases the
magnitude of MOC-mediated DPOAE suppression, suggests
that it is the slow effects of ACh that are responsible for its
protective action, rather than the hyperpolarization-induced
decrease in electromotility.
There are two fundamentally different ways in which slow
effects of a9 activation could reduce acoustic injury: (1) by
reducing mechanical vibration of the sensory epithelium, or
(2) via intracellular modiﬁcations of OHCs arising as other
downstream effects of the calcium entry through a9a10
receptors. The further observation that in the a9L99T
mutants, protection was seen only for exposures intense
enough to produce irreversible damage and permanent
threshold shifts, and not in less traumatic exposures
producing only reversible changes, argues against a general
reduction of vibration amplitude as the underlying mecha-
nism. Most of the permanent threshold elevation underlying
this type of noise exposure arises from damage to the hair cell
stereocilia bundles, including disarray loss and/or fusion of
these modiﬁed microvilli [50], which house the mechano-
electric transduction channels. Further insight into the
mechanisms linking calcium entry through nAChRs and
protection from acoustic injury will require a clearer
delineation of the molecular events leading up to this type
of noise-induced stereocilia damage.
Conclusions
This work shows that a point mutation in the hair cell’s
nAChR produces dramatic prolongation of efferent MOC
inhibitory effects at both cellular and systems levels. This
alteration provides enhanced protection from permanent
acoustic trauma, indicating that cholinergic synaptic feedback
is not only necessary, but sufﬁcient for this effect. In addition,
the enhanced activity of the modiﬁed nAChR revealed a novel
tonic inhibitory effect, raising baseline acoustic thresholds
over those of wild-type littermates, conﬁrming the inhibitory
nature of the MOC efferent system. Thus, this a9L99T knockin
presents new insights into the cellular mechanisms of
cholinergic inhibition, as well as a promising model in which
to probe the functional role of MOC efferents. In addition, the
hair cell’s efferent synapse, much like the neuromuscular
junction, can provide insights into cholinergic signaling, and
promises to be an equally informative model for studying
activity-dependent synaptic function.
Materials and Methods
Genetic engineering and genotyping of Chrna9L99T knockin
mutant mice. A HindIII-NotI (the latter derived from the construction
of the library) restriction endonuclease fragment of approximately
9,500 bp encoding Chrna9 exons 1–4 (see GenBank accession number
NT_039305.7 and Figure 2A) was obtained from a mouse strain
129S4/SvJae genomic DNA library (kindly provided by Dr Bernhard
Bettler, University of Basel) and subcloned into the vector pKO-Select
DT (Lexicon Genetics). A 2-kbp neomycin resistance cassette ﬂanked
by two loxP sites (loxP-neo-loxP) was inserted in the NcoI restriction
site within the intron located between exons 3 and 4 and the
Chrna9L99T mutation (*) introduced via site-directed mutagenesis
using the QuickChange Site-Directed Mutagenesis kit (Stratagene)
and amplimers A9sense (59-CTCTGGGAGTGACCATCCTAacGGC-
CATGACTGTATTTCAGC-39) and A9antisense (59-GCTGAAATA-
CAGTCATGGCCgtTAGGATGGTCACTCCCAGAG-39). This
targeting vector was used to electroporate 129S4/SvJae embryonic
stem (ES) cells, and homologous recombinants were obtained
following gentamicin (G418) selection and Southern blot hybrid-
ization analyses. Genomic DNA was puriﬁed from G418-resistant ES
cell clones, digested with HindIII and KpnI, electrophoresed on 0.8%
agarose, and hybridized to a
32P-labled DNA 962-bp SacII-KpnI
fragment probe prepared from the DNA fragment shown in Figure
2A. Based on the sequence of the mouse Chrna9 subunit gene (see
GenBank accession number NT_039305.7), wild-type ES cell DNA
yielded a fragment of 13,800 bp, whereas ES cells that have undergone
homologous recombination yielded a 7,300-bp fragment (see Figure
2B). Transfection of the linearized targeting vector into murine ES
cells resulted in the insertion of the L99T mutation into the a9 nAChR
subunit. The frequency of homologous recombination events in ES
cells was 42%. Six independent ES cell lines carrying the mutation
were injected into blastocysts to generate germline chimeric males
and were then implanted into pseudopregnant females. Chimeric
male progeny mice were backcrossed to strain C57BL/6J females, and
agouti coat color was used to assess the germline status of the targeted
allele. Founder males were backcrossed to wild-type 129S4/SvJae
females and heterozygous N1 females mated to cre-expressing trans-
genic males (FVB/N-Tg(EIIa-cre)C5379Lmgd/J, stock 003314; Jackson
Laboratory) to remove the ‘‘ﬂoxed’’ neomycin resistance cassette. The
excision of the neo cassette and subsequent segregation and loss of the
cre transgene were monitored via PCR. The single loxP site footprint
Figure 10. Mutant Mice Are More Resistant to Permanent Acoustic Injury
(A) Permanent noise-induced threshold shift measured 1 wk after
exposure to an 8–16-kHz noise band at 100 dB for 2 h.
(B) Temporary noise-induced threshold shifts measured 6 h after
exposure to the same noise band at 94 dB for 15 min. Each panel
shows mean thresholds 6 S.E.M. for the group, with group sizes
indicated in the symbol key.
WT, wild type.
doi:10.1371/journal.pbio.1000018.g010
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conﬁrmed by DNA sequencing.
The Chrna9L99T mutant allele has been maintained in congenic
FVB.129P2-Pde6bþ Tyrc-ch/AntJ (stock number 004828; Jackson Labo-
ratory) strain. C57BL/6J mice develop a marked and progressive late-
onset hearing loss characterized by cochlear degeneration. The FVB
background lacks this hearing loss. Moreover, the wild-type Pde6b
allele avoids blindness due to retinal degeneration typical of the FBV
strain. All experiments reported in this paper were performed using
neo-deleted Chrna9
wt/wt, Chrna9
wt/L99T,o rChrna9
L99T/L99T mutant mice
backcrossed with congenic FVB.129P2-Pde6bþ Tyrc-ch/AntJ stock for
four to ﬁve generations (i.e., N4–N5).
Routine genotyping of Chrna9 mice was performed using tail
biopsy tissue DNA samples (Wizard Genomic DNA Puriﬁcation kit;
Promega), amplimers A9LOXP.1 (59-TAC TGG CTA TCC TCC AGA
CAG AGC-39) and A9LOXP.2 (59-AGG AGC GAG CAG AGG TCC
TAA ATT-39) (see Figure 2A), and Failsafe PCR System Kit with buffer
D (Epicentre) as described by the manufacturer. PCR cycle
parameters were: 95 8C, 0.5 min; 55 8C, 1.0 min; and 72 8C, 2 min
for a total of 35 cycles. Reaction products were electrophoresed on
1.5% agarose, stained with ethidium bromide, and photographed.
The PCR fragment length for the wild-type Chrna9 allele is 203 bp and
269 bp for the mutant allele (see Figure 2C). In each breeding pair,
the mutant status of the Chrna9L999T was assessed by sequencing of
the PCR fragment obtained with amplimers L9T59 (59-
CTCTCTGACTTCATTGAAGACG-39) and L9T39 (59-CCGCACACA-
TACAGGGTTCGAT-39) (Figure 2D).
Electrophysiological recordings from cochlear hair cells. Mice were
sacriﬁced by decapitation. All experimental protocols were carried
out in accordance with the American Veterinary Medical Associa-
tions’ AVMA Guidelines on Euthanasia (June 2007). Apical turns of the
organ of Corti were excised from mice at postnatal ages P6–P11 for
IHCs and P10–P11 for OHCs, and used within 3 h. Day of birth was
considered postnatal day 0 (P0). Cochlear preparations were
mounted under a Leica DMLFS microscope (Leica Microsystems)
and viewed with differential interference contrast (DIC) using a 403
water immersion objective and a Hamamatsu C7500–50 camera with
contrast enhancement (Hamamatsu). Methods to record from IHCs
and OHCs were essentially as described previously [17,19].
Brieﬂy, hair cells were identiﬁed visually with the 403objective and
duringrecordings,by the size of their capacitance (7 to 12 pF), by their
characteristic voltage-dependent Na
þand K
þcurrents [51]. Some cells
were removed to access IHCs, but mostly, the pipette moved through
the tissue under positive pressure. The extracellular solution was as
follows (in mM): 155 NaCl, 5.8 KCl, 1.3 CaCl2, 0.9 MgCl2, 0.7 NaH2PO4,
5.6 D-glucose, and 10 Hepes buffer (pH 7.4). Two different pipette
solutions were used. One contained (in mM): 150 KCl, 3.5 MgCl2, 0.1
CaCl2, 5 ethyleneglycol-bis(b-aminoethyl ether)-N,N,N9,N9- teraacetic
acid (EGTA), 5 Hepes buffer, 2.5 Na2ATP, pH 7.2 (KCl-EGTA saline).
In the other, EGTA was replaced with 10 mM bis(2-aminophenoxy)-
ethane-N,N,N9,N9-tetra-acetic acid (BAPTA) (KCl-BAPTA saline). The
latter solution was used where indicated, in order to record the
current through the ACh receptor in isolation from the coupled SK2
current (nAChR-only). In addition, in the latter condition, the SK
blocker apamine (5 nM) was added to the recording solution.
Solutions containing ACh or high K
þ were applied by a gravity-fed
multichannel glass pipette (;150 lm tip diameter), positioned about
300 lm from the recorded cell. All working solutions containing
either ACh or elevated K
þ or both, were made up in a saline
containing low Ca
2þ (0.5 mM) and no Mg
2þ so as to optimize the
experimental conditions for measuring currents ﬂowing through the
a9a10 receptors [38]. sIPSCs were recorded immediately after
rupturing into the cell, in the extracellular saline containing 1.3
mM Ca
2þ and no Mg
2þ. All experiments designed to record synaptic
currents, either spontaneous or evoked with high K
þ, were done using
an extracellular solution containing 1.3 mM Ca
2þand no Mg
2þ. sIPSCs
were recorded immediately after rupturing the cell.
Glass pipettes, 1.2-mm I.D., had resistances of 5–8 MX. Currents in
both IHCs and OHCs were recorded in the whole-cell patch-clamp
mode with an Axopatch 200B ampliﬁer, low-pass ﬁltered at 2–10 kHz,
and digitized at 5–20 kHz with a Digidata 1322A board (Molecular
Devices). Recordings were made at room temperature (22–25 8C).
Holding potentials were not corrected for liquid junction potentials
or for the voltage drop across the uncompensated series resistance.
IPSCs were analyzed with Minianalyis (Synaptosoft; Jaejin Software).
IPSCs were identiﬁed using a search routine for event detection and
conﬁrmed by eye. The individual events of each cell were aligned and
averaged using Minianalysis. Rise time was used as the criterion to
align. For further analysis, Prism 4 (GraphPad Software) was used.
The srise and sdecay were ﬁt to a monoexponential.
Prolonged agonist application responses and concentration-
response curves to ACh in IHCs were performed in the nAChR-only
condition, normalized to the maximal agonist response, and
iteratively ﬁtted with the equation: I/Imax ¼ A
n/(A
n þ EC50
n), where I
is the peak inward current evoked by agonist at concentration A; Imax
is current evoked by the concentration of agonist eliciting a maximal
response; EC50 is the concentration of agonist inducing half-maximal
current response, and n is the Hill coefﬁcient.
Auditory brainstem responses and distortion product otoacoustic
emissions. Mice were anesthetized with xylazine (20 mg/kg i.p.) and
ketamine (100 mg/kg i.p.). DPOAEs at 2f1–f2 were recorded with a
custom acoustic assembly consisting of two electrostatic drivers (TDT
EC-1; Tucker-Davis Technologies) to generate primary tones (f1 and
f2 with f2/f1 ¼ 1.2 and f2 level 10 dB , f1 level) and a Knowles
miniature microphone (EK3103) to record ear-canal sound pressure.
Stimuli were generated digitally, while resultant ear-canal sound
pressure was ampliﬁed and digitally sampled at 4 ls (16-bit DAQ
boards, NI 6052E; National Instruments). Fast Fourier Transforms
were computed and averaged over ﬁve consecutive waveform traces,
and 2f1–f2 DPOAE amplitude and surrounding noise ﬂoor were
extracted. Iso-response curves were interpolated from plots of
amplitude versus sound level, performed in 5-dB steps of f1 level.
‘‘Threshold’’ is deﬁned as the f1 level required to produce a DPOAE
with amplitude ¼ 0 dB sound pressure level (SPL). For measurement
of ABRs, needle electrodes were inserted at vertex and pinna, with a
ground near the tail. ABRs were evoked with 5-ms tone pips (0.5-ms
rise-fall, cos
2 onset, at 35/s). The response was ampliﬁed (10,0003),
ﬁltered (100 Hz–3 kHz), and averaged with an A-D board in a
LabVIEW-driven data-acquisition system. Sound level was raised in 5-
dB steps from 10 dB below threshold to 80 dB SPL. At each level,
1,024 responses were averaged (with stimulus polarity alternated),
using an ‘‘artifact reject’’ whereby response waveforms were
discarded when peak-to-peak amplitude exceeded 15 lV. Upon
visual inspection of stacked waveforms, ‘‘threshold’’ was deﬁned as
the lowest SPL level at which any wave could be detected, usually the
level step just below that at which the response amplitude exceeded
the noise ﬂoor (;0.25 lV). For amplitude versus level functions,
wave-I peak was identiﬁed by visual inspection at each sound level
and the peak-to-peak amplitude computed.
Olivocochlear assay. Mice were anesthetized with urethane (1.20 g/
kg i.p.) and xylazine (20 mg/kg i.p.). A posterior craniotomy and
partial cerebellar aspiration were performed to expose the ﬂoor of
the IVth ventricle. To stimulate the MOC bundle, shocks (monophasic
pulses, 150-ls duration, 200/s) were applied through ﬁne silver wires
(0.4-mm spacing) placed along the midline, spanning the olivoco-
chlear decussation. Shock threshold for facial twitches was deter-
mined, muscle paralysis induced with a-d-tubocurarine (1.25 mg/kg
i.p.), and the animal connected to a respirator via a tracheal cannula.
Shock levels were raised to 6 dB above twitch threshold. During the
MOC suppression assay, f2 level was set to produce a DPOAE 10–15
dB or 20–25 dB greater than the noise ﬂoor. To measure MOC effects,
repeated measures of baseline DPOAE amplitude were ﬁrst obtained
(n ¼ 56), followed by a series of 70 contiguous periods in which
DPOAE amplitudes were measured with simultaneous shocks to the
MOC bundle and additional periods during which DPOAE measures
continued after the termination of the shock train.
Acoustic overexposure. Animals were exposed free-ﬁeld, in a small
reverberant chamber. Acoustic trauma consisted of a 2-h exposure to
an 8–16-kHz octave band noise presented at 100 dB SPL (for
permanent injury) or a 15-min exposure to the same noise at 94 dB
SPL (for temporary injury). For the higher level exposure, animals
were anesthetized (ketamine and xylazine, exactly as for the ABR and
DPOAE testing), because many mutant animals experienced audio-
genic seizures as soon as the high-level noise was turned on. The
exposure stimulus was generated by a custom white-noise source,
ﬁltered (Brickwall Filter with a 60-dB/octave slope), ampliﬁed (Crown
power ampliﬁer), and delivered (JBL compression driver) through an
exponential horn ﬁtted securely to a hole in the top of a reverberant
box. Sound exposure levels were measured at four positions within
each cage using a 0.25’’ Bruel and Kjaer condenser microphone:
sound pressure was found to vary by less than 0.5 dB across these
measurement positions.
Data analysis. Statistical analyses of in vitro electrophysiology
experiments were carried by the Student t-test in the case of pairwise
comparisons or a one-way ANOVA followed by a Dunnet test for
multiple comparisons. In the case of in vivo data, a two-way ANOVA
was performed. A p , 0.05 was selected as the criterion for statistical
signiﬁcance. Mean values are quoted as means 6 the standard error
of the mean (S.E.M.).
Materials. ACh chloride, strychnine HCl, Na2ATP, BAPTA, and all
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a9 nAChR Point Mutant & Noise Protectionother reagents were from Sigma Chemical. EGTA and Na2ATP were
dissolved at the moment of preparing the intracellular solutions.
Animal welfare. All experimental protocols were carried out in
accordance with the National Institutes of Health guide for the care
and use of laboratory animals as well as Instituto de Investigaciones
en Ingenierı ´a Gene ´tica y Biologı ´a Molecular (INGEBI), Tufts
University, and Massachusetts Eye and Ear Inﬁrmary Institutional
Animal Care and Use Committee (IACUC) guidelines, and best
practice procedures.
Supporting Information
Figure S1. Morphology of the Cochlear Duct Is Normal in Mutant
Ears
Gross histological assessment via plastic sections of osmium-stained
Chrna9
L99T/L99T cochleae showed no morphological changes when
compared to Chrna9
wt/wt. Sections through the middle turn are shown.
Black and grey arrows in Chrna9
wt/wt indicate OHCs and IHCs,
respectively. Histological procedures were performed as described in
Text S1.
Found at doi:10.1371/journal.pbio.1000018.sg001 (2.38 MB TIF).
Figure S2. Voltage-Dependent K
þ Currents from IHCs and OHCs
(A) Voltage-dependent currents obtained in P6–P10 IHCs by holding
the cell at  80 mV and stepping the voltage to 80 mV in 10-mV
increments (200-ms duration). Representative traces are shown for
the three genotypes as well as for averaged steady state current-
voltage curves (Chrna9
wt/wt; n¼10 animals, 13 cells; Chrna9
wt/L99T: n¼9
animals, 13 cells; and Chrna9
L99T/L99T: n¼14 animals, 17 cells); (B) same
as in (A), but for P10–P14 OHCs (Chrna9
wt/wt; n¼2 animals, 3 cells; and
Chrna9
L99T/L99T: n ¼ 6 animals, 8 cells).
Found at doi:10.1371/journal.pbio.1000018.sg002 (225 KB TIF).
Figure S3. D o s e - R e s p o n s eC u r v ef o rS t r y c h n i n eB l o c k a d eo f
Cholinergic OC Effects on DPOAE Thresholds
Each point shows data from different animals extracted from runs
such as those shown in Figure 8 (f2¼22.6 kHz). All data were collected
60 min after strychnine injection. Although thresholds in wild-type
mice slightly rise with strychnine dosage, thresholds in knockin mice
improve by as much as 8 dB.
Found at doi:10.1371/journal.pbio.1000018.sg003 (117 KB TIF).
Table S1. Analysis of Gene Expression by Quantitative PCR
Chrna9:g e n ee n c o d i n gt h ea9n A C h Rs u b u n i t ;Chrna10:g e n e
encoding the a10 nAChR subunit; Kcnn2: gene encoding the SK2
channel; Ryr1: gene encoding the ryanodine receptor 1; Ryr2: gene
encoding the ryanodine receptor 2; Ryr3:g e n ee n c o d i n gt h e
ryanodine receptor 3; Kcnmb1: gene encoding the calcium-activated
potassium channel (BK) b-1subunit; Cacna1d: gene encoding the
voltage-gated calcium channel alpha subunit CaV1.3; Myo7a: gene
encoding myosin VIIa. CTs: threshold cycle of sample; CTm: threshold
cycle of Myo7a. Results shown are the mean 6 S.E.M of three
experiments per group, each performed in triplicates. The protocol
for quantitative PCR was as indicated in Text S2.
Found at doi:10.1371/journal.pbio.1000018.st001 (88 KB DOC).
Text S1. Histology of the Cochlear Duct
Found at doi:10.1371/journal.pbio.1000018.sd001 (24 KB DOC).
Text S2. Quantitative PCR
Found at doi:10.1371/journal.pbio.1000018.sd002 (27 KB DOC).
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